The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

Scientists at Ankara University (AU) have developed an artificial intelligence-supported application that could enable the ...

Chinese regulator grants second approval for lung cancer drug ivonescimab, which has outperformed Merck’s Keytruda in phase ...

Diliman has identified potential biomarkers or signs that can help with early lung cancer detection with the support of the ...

A group of scientists from the University of the Philippines (UP) Diliman has identified potential biomarkers for lung cancer that could help in detecting and determining ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Li Qiang, director of the respiratory and critical care medicine department at the hospital, said the patient had over 10 ...

Jack Owens, 20, will be cycling across the US this summer to benefit Ride Hard Breathe Easy in memory of his Irish granny ...

Zongertinib shows promise for treating HER2-mutant non–small cell lung cancer (NSCLC), with significant activity against brain metastases and low interstitial lung disease risk, explains John Heymach, ...

With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

Turkish scientists have developed an artificial intelligence-supported application designed to detect lung cancer at an early ...